Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

NCT01286649 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

OTHER: Human autologous hair follicle cells
OTHER: Cell medium

Sponsor

TrichoScience Innovations, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]